Zobrazeno 1 - 10
of 986
pro vyhledávání: '"Villafranca E"'
Autor:
Johansen, J.G., Jürgenliemk-Schulz, I.M., Haddad, H., Hannoun-Levi, J.M., Hellebust, T.P., Guix, B., Loessl, K., Pieters, B., Rao, C., Strnad, V., Sturdza, A.E., Tagliaferri, L., Takacsi-Nagy, Z., Villafranca, E., Wojcieszek, P., Rembielak, A., Niehoff, P.
Publikováno v:
In Clinical and Translational Radiation Oncology January 2025 50
Autor:
Sutera, D
The contribution traces the story relating to the construction of the tower facade of the Mother Church of Salaparuta, destroyed by the earthquake of the Belice Valley in 1968 and of which there are, in addition to the historical iconography, also ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3658::0787218c66fb98f81d14e5331a169b3a
http://hdl.handle.net/10447/562548
http://hdl.handle.net/10447/562548
Autor:
Johansen JG; Aarhus University, Department of Clinical Medicine, Aarhus, Denmark.; Aarhus University Hospital, Danish Centre for Particle Therapy, Aarhus, Denmark., Jürgenliemk-Schulz IM; UMCU, Radiation Oncology, Utrecht, the Netherlands., Haddad H; Tuebingen University Hospital and Medical Faculty, Eberhard Karls University of Tübingen, Department of Radiation Oncology, Tübingen, Germany., Hannoun-Levi JM; Antoine Lacassagne Cancer Center, Radiation Oncology, University Coete d'Azur, Nice, France., Hellebust TP; Oslo University Hospital, Department of Medical Physics, Oslo, Norway., Guix B; Fundación IMOR, ATRYS, Radiation Oncology, Barcelona, Spain., Loessl K; Inselspital, Bern University Hospital, University of Bern, Clinic of Radiation Oncology, Bern, Switzerland., Pieters B; Amsterdam University Medical Center, University of Amsterdam, the Netherlands.; Cancer Center Amsterdam, Cancer Treatment and Quality of Life, Amsterdam, the Netherlands., Rao C; Imperial College London, Surgery and Cancer, London, United Kingdom.; Cumberland Infirmary, Colorectal Surgery, Carlisle, United Kingdom., Strnad V; University Hospital Erlangen, Department of Radiation Oncology, Erlangen, Germany., Sturdza AE; Medical University of Vienna, Radiation Oncology, Vienna, Austria., Tagliaferri L; Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Radiotherapy, Rome, Italy., Takacsi-Nagy Z; National Institute of Oncology, Department of Radiotherapy and National Tumor Biology Laboratory and Semmelweis University, Department Of Oncology, Budapest, Hungary., Villafranca E; Hospital Universitario de Navarra, Radiation Oncology, Pamplona, Spain., Wojcieszek P; MSC National Research Institute of Oncology, Gliwice Branch, Brachytherapy Department, Gliwice, Poland., Rembielak A; The Christie NHS Foundation Trust, Clinical Oncology, Manchester, United Kingdom.; The University of Manchester, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester, United Kingdom., Niehoff P; Sana Kliniken Offenbach, Dep. Of Radiotherapy, Offenbach, Germany.
Publikováno v:
Clinical and translational radiation oncology [Clin Transl Radiat Oncol] 2024 Nov 02; Vol. 50, pp. 100883. Date of Electronic Publication: 2024 Nov 02 (Print Publication: 2025).
Autor:
Rodolico, Niccolò
Publikováno v:
Archivio Storico Italiano, 1961 Jan 01. 1191 (429), 120-123.
Externí odkaz:
https://www.jstor.org/stable/26250434
Autor:
Guinot JL; Radiation Oncology Department, Fundacion Instituto Valenciano de Oncologia (I.V.O.), C/Profesor Beltran Baguena 8, 46009, Valencia, Spain. jguinot@fivo.org., Diezhandino P; Radiation Oncology Department, Hospital Clinico Universitario de Valladolid, Valladolid, Spain., de Frutos JM; Radiation Oncology Department, Hospital Clinico Universitario de Valladolid, Valladolid, Spain., Fuentemilla N; Radiation Oncology Department, Hospital Universitario de Navarra, Pamplona, Spain., Gonzalez-Perez V; Department of Medical Physics, Fundacion Instituto Valenciano de Oncologia (I.V.O.), Valencia, Spain., Gutierrez C; Department of Radiation Oncology, Institut Català d'Oncologia, Barcelona, Spain., Herreros A; Radiation Oncology Department, Hospital Clínic Universitari, Barcelona, Spain., Martinez-Monge R; Department of Oncology, Clínica Universitaria de Navarra, CUN, Pamplona, Spain., Perez-Echagüen S; Radiation Oncology Department, CIBIR - Complejo Hospitalario San Pedro La Rioja, Logroño, Spain., Pino F; Department of Medical Physics, Institut Català d'Oncologia, Barcelona, Spain., Roldán S; Radiation Oncology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain., Rovirosa A; Radiation Oncology Department, Hospital Clínic Universitari, Barcelona, Spain., Santos MA; Radiation Oncology Department, Fundacion Instituto Valenciano de Oncologia (I.V.O.), C/Profesor Beltran Baguena 8, 46009, Valencia, Spain., Sanz-Freire CJ; Medical Physics Department, CIBIR - Complejo Hospitalario San Pedro La Rioja, Logroño, Spain., Villafranca E; Radiation Oncology Department, Hospital Universitario de Navarra, Pamplona, Spain.
Publikováno v:
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2024 Feb; Vol. 26 (2), pp. 456-460. Date of Electronic Publication: 2023 Aug 07.
Autor:
Spampinato S; Danish Center for Particle Therapy, Aarhus University Hospital, 8200 Aarhus, Denmark. Electronic address: sofspa@rm.dk., Tanderup K; Danish Center for Particle Therapy, Aarhus University Hospital, 8200 Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, 8200 Aarhus, Denmark. Electronic address: karitand@rm.dk., Lindegaard JC; Department of Oncology, Aarhus University Hospital, 8200 Aarhus, Denmark. Electronic address: jacob.lindegaard@auh.rm.dk., Schmid MP; Department of Radiation Oncology, Comprehensive Cancer Center, Medical University of Vienna, 1090 Vienna, Austria. Electronic address: maximilian.schmid@akhwien.at., Sturdza A; Department of Radiation Oncology, Comprehensive Cancer Center, Medical University of Vienna, 1090 Vienna, Austria. Electronic address: alina.sturdza@akhwien.at., Segedin B; Department of Radiotherapy, Institute of Oncology, 1000 Ljubljana, Slovenia; Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia. Electronic address: bsegedin@onko-i.si., Jürgenliemk-Schulz IM; Department of Radiation Oncology, University Medical Centre Utrecht, 3584 CX Utrecht, the Netherlands. Electronic address: I.M.Schulz@umcutrecht.nl., De Leeuw A; Department of Radiation Oncology, University Medical Centre Utrecht, 3584 CX Utrecht, the Netherlands. Electronic address: astrid.a.c.deleeuw@gmail.com., Bruheim K; Department of Oncology, Oslo University Hospital, 0450 Oslo, Norway. Electronic address: uxkjuh@ous-hf.no., Mahantshetty U; Department of Radiation Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai and Homi Bhabha Cancer Hospital and Research Centre, Visakhapatnam, Andhra Pradesh 530053, India. Electronic address: drumeshm@gmail.com., Chargari C; Department of Radiation Oncology, Gustave Roussy Cancer Campus, 94805 Villejuif, France. Electronic address: Cyrus.CHARGARI@gustaveroussy.fr., Rai B; Department of Radiotherapy and Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India. Electronic address: bhavana1035@gmail.com., Cooper R; Leeds Cancer Centre, St James's University Hospital, Leeds LS9 7LP, United Kingdom. Electronic address: Rachel.cooper1@nhs.net., van der Steen-Banasik E; Department of Radiotherapy, Radiotherapiegroep Arnhem, 6815 AD Arnhem, the Netherlands. Electronic address: E.vanderSteen-Banasik@radiotherapiegroep.nl., Sundset M; Clinic of Oncology and Women's Clinic, St. Olavs Hospital, 7030 Trondheim, Norway. Electronic address: marit.sundset@stolav.no., Wiebe E; Department of Oncology, Cross Cancer Institute and University of Alberta, Edmonton AB T6G 1Z2, Canada. Electronic address: Ericka.Wiebe@albertahealthservices.ca., Villafranca E; Department of Radiation Oncology, Hospital of Navarra, 31008 Pamplona, Navarra, Spain. Electronic address: elena.villafranca.iturre@cfnavarra.es., Van Limbergen E; Department of Radiation Oncology, University Hospital Leuven, 3000 Leuven, Belgium. Electronic address: erik.vanlimbergen@uz.kuleuven.ac.be., Pieters BR; Department of Radiation Oncology, Amsterdam University Medical Centers, University of Amsterdam, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Cancer Treatment and Quality of Life, 1081 HV Amsterdam, the Netherlands. Electronic address: b.r.pieters@amc.uva.nl., Tee Tan L; Oncology Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, United Kingdom. Electronic address: litee.tan@addenbrookes.nhs.uk., Lutgens LCHW; Maastricht Radiation Oncology (MAASTRO) clinic, 6229 ET Maastricht, the Netherlands. Electronic address: ludy.lutgens@maastro.nl., Hoskin P; Mount Vernon Cancer Centre, Mount Vernon Hospital, Northwood HA6 2RN, United Kingdom. Electronic address: peterhoskin@nhs.net., Smet S; Department of Radiation Oncology, Algemeen Ziekenhuis Turnhout, 2300 Turnhout, Belgium. Electronic address: stephanie_smet99@hotmail.com., Pötter R; Department of Radiation Oncology, Comprehensive Cancer Center, Medical University of Vienna, 1090 Vienna, Austria. Electronic address: Richard.Poetter@akhwien.at., Nout R; Department of Clinical Oncology, Leiden University Medical Center, 2333 ZA Leiden, the Netherlands. Electronic address: r.nout@erasmusmc.nl., Chopra S; Department of Radiation Oncology, Advanced Centre for Treatment Research and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Navi Mumbai 410210, India. Electronic address: supriyasastri@gmail.com., Kirchheiner K; Department of Radiation Oncology, Comprehensive Cancer Center, Medical University of Vienna, 1090 Vienna, Austria. Electronic address: Kathrin.Kirchheiner@akhwien.at.
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2023 Apr; Vol. 181, pp. 109501. Date of Electronic Publication: 2023 Jan 30.
Autor:
Pötter R., Tanderup K., Schmid M.P., Jürgenliemk-Schulz I., Haie-Meder C., Fokdal L.U., Sturdza A.E., Hoskin P., Mahantshetty U., Segedin B., Bruheim K., Huang F., Rai B., Cooper R., van der Steen-Banasik E., Van Limbergen E., Pieters B.R., Tan L.-T., Nout R.A., De Leeuw A.A.C., Ristl R., Petric P., Nesvacil N., Kirchheiner K., Kirisits C., Lindegaard J.C., Chargari C., Dumas I., Lowe G., Swamidas J., Hudej R., Paulsen Hellebust T., Menon G., Oinam A.S., Bownes P., Christiaens M., De Brabandere M., Janssen H., Oosterveld B., Koedooder K., Langeland Marthinsen A.B., Sundset M., Whitney D., Ketelaars M., Lutgens L.C.H.W., Reinniers B., Mora I., Villafranca E., Antal G., Hadjiev J., Bachand F., Batchelar D., Erickson B., Rownd J., Jacobson G., Kim Y., Anttila M., Palmgren J.-E., An J., Assenholt M.S., Banerjee S., Bentzen S., Berger T., Dankulchai P., Diendorfer T., Dilworth I., Dimopoulos J., Dörr E., Ecker S., Federico M., Fidarova E., Fortin I., Georg P., Gora J., Hegazy N., Jastaniyah N., Jensen N.B.K., Liederer T., Majercakova K., Misimovic D., Motisi L., Najjari Jamal D., Nkiwane K., Schwartz-Vittrup A., Serban M., Smet S., Spampinato S., Trnkova P., Valgma M., Westerveld H., Wong J.S.Y., Yoshida K., EMBRACE Collaborative Group
Publikováno v:
LANCET ONCOLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Universitat Politècnica de Catalunya (UPC)
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Universitat Politècnica de Catalunya (UPC)
Background: The concept of the use of MRI for image-guided adaptive brachytherapy (IGABT) in locally advanced cervical cancer was introduced 20 years ago. Here, we report on EMBRACE-I, which aimed to evaluate local tumour control and morbidity after
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::2917ef9c5609c5612c2e8c6b4e9de40a
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85103374444&doi=10.1016/S1470-2045(20)30753-1&partnerID=40&md5=77779ce29d6a7edc2477d87dd5900105
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85103374444&doi=10.1016/S1470-2045(20)30753-1&partnerID=40&md5=77779ce29d6a7edc2477d87dd5900105
Autor:
Potter, R., Tanderup, K., Kirisits, C., Leeuw, A. de, Kirchheiner, K., Nout, R., Tan, L.T., Haie-Meder, C., Mahantshetty, U., Segedin, B., Hoskin, P., Bruheim, K., Rai, B., Huang, F., Limbergen, E. van, Schmid, M., Nesvacil, N., Sturdza, A., Fokdal, L., Jensen, N.B.K., Georg, D., Assenholt, M., Seppenwoolde, Y., Nomden, C., Fortin, I., Chopra, S., Heide, U. van der, Rumpold, T., Lindegaard, J.C., Jurgenliemk-Schulz, I., Dumas, I., Chargari, C., Swamidas, J., Shrivastava, S.K., Lowe, G., Hudej, R., Hellebust, T.P., Menon, G., Oinam, A.S., Cooper, R., Bownes, P., Banasik, E.V., Sundset, M., Pieters, B., Lutgens, L.C.H.W., Villafranca, E., Hadjiev, J., Bachand, F., Erickson, B., Jacobson, G., Anttila, M., EMBRACE Collaborative Grp
Publikováno v:
EMBRACE Collaborative Group 2018, ' The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies ', Clinical and Translational Radiation Oncology, vol. 9, pp. 48-60 . https://doi.org/10.1016/j.ctro.2018.01.001
Clinical and Translational Radiation Oncology, Vol 9, Iss C, Pp 48-60 (2018)
EMBRACE Collaborative Group 2018, ' The EMBRACE II study : The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies ', Clinical and translational radiation oncology, vol. 9, pp. 48-60 . https://doi.org/10.1016/j.ctro.2018.01.001
Clinical and Translational Radiation Oncology
Clinical and Translational Radiation Oncology, Vol 9, Iss C, Pp 48-60 (2018)
EMBRACE Collaborative Group 2018, ' The EMBRACE II study : The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies ', Clinical and translational radiation oncology, vol. 9, pp. 48-60 . https://doi.org/10.1016/j.ctro.2018.01.001
Clinical and Translational Radiation Oncology
Graphical abstract
Highlights • Image guided adaptive brachytherapy (IGABT) is changing clinical practice. • The EMBRACE studies benchmark IGABT in cervix cancer. • A multi-parametric dose prescription protocol is being validated in EMBRAC
Highlights • Image guided adaptive brachytherapy (IGABT) is changing clinical practice. • The EMBRACE studies benchmark IGABT in cervix cancer. • A multi-parametric dose prescription protocol is being validated in EMBRAC
Autor:
Otal A; Medical Physics Department, Hospital Universitari Arnau de Vilanova, 25198 Lleida, Spain.; Unidad Mixta de Investigación en Radiofísica e Instrumentación Nuclear en Medicina (IRIMED), Instituto de Investigación Sanitaria La Fe (IIS-La Fe), Universitat de Valencia (UV), 46010 Valencia, Spain., Celada F; Radiotherapy Department, La Fe Hospital, 46026 Valencia, Spain., Chimeno J; Medical Physics Department, Hospital San Juan, 03550 Alicante, Spain., Vijande J; Unidad Mixta de Investigación en Radiofísica e Instrumentación Nuclear en Medicina (IRIMED), Instituto de Investigación Sanitaria La Fe (IIS-La Fe), Universitat de Valencia (UV), 46010 Valencia, Spain.; Department of Atomic, Molecular and Nuclear Physics, University of Valencia, 46010 Valencia, Spain.; Instituto de Física Corpuscular, IFIC (UV-CSIC), 46010 Valencia, Spain., Pellejero S; Radiation Oncology Department, Hospital Universitario de Navarra, 31008 Navarre, Spain., Perez-Calatayud MJ; Radiotherapy Department, La Fe Hospital, 46026 Valencia, Spain., Villafranca E; Radiation Oncology Department, Hospital Universitario de Navarra, 31008 Navarre, Spain., Fuentemilla N; Radiation Oncology Department, Hospital Universitario de Navarra, 31008 Navarre, Spain., Blazquez F; Radiotherapy Department, Hospital Clínica Benidorm, 03501 Alicante, Spain., Rodriguez S; Radiotherapy Department, Hospital Clínica Benidorm, 03501 Alicante, Spain., Perez-Calatayud J; Unidad Mixta de Investigación en Radiofísica e Instrumentación Nuclear en Medicina (IRIMED), Instituto de Investigación Sanitaria La Fe (IIS-La Fe), Universitat de Valencia (UV), 46010 Valencia, Spain.; Radiotherapy Department, La Fe Hospital, 46026 Valencia, Spain.; Radiotherapy Department, Hospital Clínica Benidorm, 03501 Alicante, Spain.
Publikováno v:
Cancers [Cancers (Basel)] 2022 Jul 17; Vol. 14 (14). Date of Electronic Publication: 2022 Jul 17.
Autor:
Lara PC; Canarian Comprehensive Cancer Center, San Roque University Hospital, Fernando Pessoa Canarias University, Las Palmas, Spain., Rodríguez-Melcón JI; Radiation Oncology. Dr. Negrín University Hospital, Las Palmas, Spain., Palacios-Eito A; Radiation Oncology, Reina Sofía University Hospital, Instituto Maimónides de Investigación Biomédica de Córdoba, Córdoba, Spain., Lozano A; Radiation Oncology, Virgen de la Arriexaca University Hospital, Murcia, Spain., Hervás-Morón A; Radiation Oncology, Ramon y Cajal University Hospital, Madrid, Spain., Villafranca E; Radiation Oncology, Navarra University Hospital, Pamplona, Spain., Gómez-Iturriaga A; Radiation Oncology, Cruces University Hospital, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain., Sancho G; Radiation Oncology, San Creu I San Pau University Hospital, Barcelona, Spain., Maldonado X; Radiation Oncology, Vall d´Hebron University Hospital, Barcelona, Spain.
Publikováno v:
Frontiers in oncology [Front Oncol] 2022 Jul 14; Vol. 12, pp. 891886. Date of Electronic Publication: 2022 Jul 14 (Print Publication: 2022).